{"id":3613,"date":"2020-03-20T10:00:20","date_gmt":"2020-03-20T00:00:20","guid":{"rendered":"https:\/\/news.sap.com\/australia\/?p=3613"},"modified":"2020-03-20T10:00:21","modified_gmt":"2020-03-20T00:00:21","slug":"sap-joins-5-for-the-fight","status":"publish","type":"post","link":"https:\/\/news.sap.com\/australia\/2020\/03\/20\/sap-joins-5-for-the-fight\/","title":{"rendered":"麻豆原创 Joins 5 For The Fight"},"content":{"rendered":"
Cancer impacts all of us \u2014 our friends and family, ourselves, coworkers and neighbours, celebrities, and strangers alike. This group of diseases does not discriminate.<\/p>\n
The World Health Organisation affirms that cancer is the second-leading cause of death globally, taking the lives of an estimated 9.6 million people in 2018 alone. One in six deaths globally is a result of cancer. These statistics are powerful, but so are we. There is no limit to what the world can accomplish if we come together in both spirit and action.<\/p>\n And we\u2019re doing it $5 at a time.<\/p>\n That\u2019s where\u00a05 For The Fight<\/strong><\/a> comes in. In honour of World Cancer Day, Qualtrics is excited to announce that 麻豆原创 SE is signing on as a 5 For The Fight company. 麻豆原创 will begin with a pilot campaign for employees in five countries: Australia, Germany, India, Singapore, and the U.S.<\/p>\n Not only are 麻豆原创 employees invited to personally take part in\u00a0giving their 5 For The Fight<\/a>, the campaign focuses on raising money for cancer researchers in these geographies through the 麻豆原创 Together program.<\/p>\n As a crowdfunding campaign for cancer research,\u00a05 For The Fight<\/strong>\u00a0is simple. Instead of a few people donating large sums of money to support this cause, the campaign suggests that everyone can help to fund the fight against cancer by donating $5, \u20ac5, or any currency. Alone, $5 may not buy much, but together our $5 donations have raised more than $24 million and has funded 10 cancer researchers globally since the program\u2019s inception in 2016.<\/p>\n \u201cSo many of us in the 麻豆原创 family have been impacted by cancer. When that diagnosis comes in, you can feel so helpless. We want to give people a way to do something \u2014 and 5 For The Fight gives people a way to say \u2018We can fight this disease,’\u201d said 5 For The Fight and Qualtrics Co-Founder Ryan Smith. \u201cOne-hundred percent of donations go directly to fighting cancer. Every year we are hiring more researchers who are helping create a cure for cancer.\u201d<\/p>\n Get to know the 5 For The Fight-funded research that 麻豆原创 is helping to support around the world.<\/p>\n Huntsman Cancer Institute<\/strong><\/p>\n Dr. Joshua Schiffman focuses on childhood cancers. A childhood cancer survivor himself, he learned a few years ago that elephants rarely get cancer and it changed everything. \u201cNature\u2019s figured it out,\u201d said Dr. Schiffman. \u201cWhy can\u2019t we? Elephants have millions more cells than [humans] and should get cancer at much higher rates, but they have evolved past it.\u201d<\/p>\n Now, instead of focusing on why people get cancer, he\u2019s focusing on why elephants do not. Dr. Schiffman and his collaborators focus on the gene p53, a tumour suppressor. Elephants have 20-times more of it than humans. Dr. Schiffman has partnered with a team of nanotechnologists testing new ways to target drug delivery by inserting synthetic elephant p53 into microscopic particles that will directly attack cancer cells.<\/p>\n Garvan Institute of Medical Research<\/strong><\/p>\n Cancer occurs when cells multiply too rapidly, forming a mass or lump. Excluding non-melanoma skin cancer, breast cancer is the most common cancer among Australian women, with oestrogen receptor positive (ER+) accounting for 70 percent of all diagnoses. Hormone therapy is an effective treatment for ER+ breast cancer, but patients can develop a resistance over time to treatment.<\/p>\n \u201cTreatment resistance is a significant health problem that leads to a third of all patients on hormone therapy relapsing within 15 years,\u201d says Dr. Joanna Achinger-Kawecka of the Garvan Institute of Medical Research.<\/p>\n For the first time, Garvan researchers have shown that the 3D structure of DNA is \u201crewired\u201d in ER+ breast cancers that have developed a resistance to hormone therapy. This rewiring alters which genes are activated and which genes are silenced in the cells, shining a light on how ER+ cancers evade hormone therapy.<\/p>\n Cancer cells are always trying to outsmart therapy and it only takes one cell to evolve a different way to bypass a drug to cause a relapse in cancer. This study shows just how much impact a change in the epigenome can have on cancer cell behaviour. The next step is to investigate whether epigenetic changes could be reversed to stop hormone resistance, using existing drugs that are already in clinical trials for other cancers.<\/p>\n Hopp Children\u2019s Cancer Centre Heidelberg<\/strong><\/p>\n Dr. Sina Oppermann at Hopp Children\u2019s Cancer Centre Heidelberg (KiTZ) passionately works to develop new innovative drugs for children with high risk and relapsed cancers. KiTZ is a joint institution of the German Cancer Research Centre<\/a>\u00a0(DFKZ), the\u00a0Heidelberg University Hospital<\/a>\u00a0(UKHD), and\u00a0Heidelberg University<\/a>.<\/p>\n As a therapy and research centre for oncologic and hematologic diseases in children and adolescents, KiTZ is committed to scientifically exploring the biology of childhood cancer and to closely linking promising research approaches with patient care \u2013 from diagnosis to treatment and aftercare.<\/p>\n National Cancer Centre Singapore<\/strong><\/p>\n Breast cancer is the most common and deadliest complex disease that afflicts Singaporean women. Based on the latest cancer registry report released in 2017, it was estimated that one in 14 women in Singapore will develop the condition before the age of 75. It creates a huge socioeconomic impact by affecting women in their economically productive years, disrupting childcare and daily function as a family unit where women are traditionally the linchpin. To add, breast cancer incidences have increased three-fold in the past four decades.<\/p>\n Breast cancer research at National Cancer Centre Singapore, which sees 65 percent of the public sector oncology cases, is crucial to improve breast cancer diagnosis, treatment, detection, and prevention.<\/p>\n
<\/a>What is 5 For The Fight?<\/strong><\/h2>\n
U.S.: Elephants Don\u2019t Get Cancer, Why Should You?<\/strong><\/h2>\n
<\/a>Australia:<\/strong>\u00a0N<\/strong>ew Path for Breast Cancer Treatment<\/strong><\/h2>\n
<\/a>Germany: Developing New Drugs for Children with Recurring Cancer<\/strong><\/h2>\n
<\/a>Singapore: Fighting the Most Common and Deadly Disease, Breast Cancer \u00a0<\/strong><\/h2>\n
<\/a>Join 麻豆原创 and Qualtrics: Give Us Your 5
\n<\/strong><\/h2>\n\n